Sir Andrew Witty

Chairman & Chief Executive Officer
GlaxoSmithKline PLC

Sir Andrew Witty became chief executive officer of GlaxoSmithKline (GSK) in 2008, and joined GSK in 1985. In 2012, he was awarded a knighthood for services to the economy and to the UK pharmaceutical industry.

Witty served as the lead non-executive board member for the Department for Business, Innovation and Skills until December 2013. He was also president of the European Federation of Pharmaceutical Industries and Associations until June 2013. Witty is a member of the Prime Minister’s business advisory group and member of the Global Health Innovation Advisory Board, Imperial College London. He is chancellor of the University of Nottingham and was appointed to the UK Business Ambassador Group in January 2014.